Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

PENUMBRA, INC.

United States·US-MF-000008514

Last updated September 17, 2026

Information

Country
United States
Address
One Penumbra Place, Alameda, United States
LinkedIn
—
Facebook
—
Phone
—
PRRC Contact
Mary Rose
EUDAMED SRN
US-MF-000008514
FDA FEI Number
3013758550
DUNS Number
191077671

Catalogue (1506)

Page 15 of 31
DeviceModel / ReferenceRegistriesClassStatus
Neuron PNS6F125BER-R
FDA UDI
Class IIActive
Indigo System CAT2
FDA UDI
Class IIActive
Red 43 RED43HFKIT160-A
FDA UDI
Class IIActive
Penumbra Coil 400 4002C1450
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT4H06
FDA UDI
Class IIActive
Neuron PNS5F120BER-R
FDA UDI
Class IIActive
Neuron PND6F10512
FDA UDI
Class IIActive
Pod RBYPODJ15
FDA UDI
Class IIActive
Neuron PNS6F125SIM
FDA UDI
Class IIActive
LP Coil System RBYLP0306
FDA UDI
Class IIActive
RUBY Coil RBY2C1440-A
FDA UDI
Class IIActive
Swift Coil System 400SWCCL510-A
FDA UDI
Class IIActive
Indigo System LITNGBT7STR130-A
FDA UDI
Class IIActive
Indigo System SEP3
FDA UDI
Class IIActive
Neuron PNML6F088904-R
FDA UDI
Class IIActive
REAL Immersive System RLE1-A
FDA UDI
NActive
Indigo System CAT8STR85-A
FDA UDI
Class IIActive
Swift Coil System 400SWCCL105-A
FDA UDI
Class IIActive
RUBY Coil RBY2C1857-B
FDA UDI
Class IIActive
LP Coil System RBYLP0415
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0412
FDA UDI
Class IIActive
Lantern Delivery Catheter PXSLIMLAN160STR
FDA UDI
Class IIActive
Penumbra Coil 400 4004C1040
FDA UDI
Class IIActive
Neuron PND6F070956
FDA UDI
Class IIActive
Neuron PNML6F0881004-R
FDA UDI
Class IIActive
Indigo System CAT12XTORQ85KIT
FDA UDI
Class IIActive
Penumbra Coil 400 4006C0305-A
FDA UDI
Class IIActive
Neuron PND6F0701058M
FDA UDI
Class IIActive
Penumbra Coil 400 4002C2060
FDA UDI
Class IIActive
RUBY Coil RBY2C3260-B
FDA UDI
Class IIActive
LP Coil System RBYPCLP15
FDA UDI
Class IIActive
REAL Immersive System REAL1V-A
FDA UDI
Class IIActive
Benchmark MAX System BMX96100H1125-B
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT3H15
FDA UDI
Class IIActive
RUBY Coil RBY2C1440-B
FDA UDI
Class IIActive
Benchmark BMK6F95M
FDA UDI
Class IIActive
LP Coil System RBYLP0104
FDA UDI
Class IIActive
Penumbra System 4MAXC130
FDA UDI
Class IIActive
Penumbra Coil 400 4004C0925-A
FDA UDI
Class IIActive
Apollo System AP9
FDA UDI
Class IIActive
Penumbra Coil 400 4004C0412-A
FDA UDI
Class IIActive
Ace 5MAXACE064L125
FDA UDI
Class IIActive
Pod RBYPOD8S
FDA UDI
Class IIActive
Penumbra Coil 400 4006U0304-A
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0406
FDA UDI
Class IIActive
LP Coil System RBYLP0105-B
FDA UDI
Class IIActive
Penumbra System 5MAXACE068L115-B
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0303
FDA UDI
Class IIActive
Indigo System LITNG12XTORQ115
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT0202
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (10)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 15, 2020Z-0848-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0851-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0850-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0849-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Jun 9, 2017Z-2702-2017—terminated

Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.

Mar 4, 2011Z-1906-2011—terminated

The diameter of a component of the device is out of tolerance specification; the Delivery Pusher pull wire which secures the coil in place can prolapse and allow premature detachment of the coil.

Oct 25, 2010Z-0428-2011—terminated

Reperfusion catheter may fail at the mid-shaft joint and may break off. If the segment cannot be removed, it may result in blocked blood flow, requiring emergency medical treatment.

Sep 22, 2009Z-0001-2010—terminated

Failure-- product can kink or ovalize, which may result in difficulty in catheter advancement or delivery of other devices and damage to catheter, which could lead to patient injury or death as a result of portions being retained in the patient.

Jul 2, 2009Z-2049-2009—terminated

Leakage-- Due to a manufacturing error, some products may have a fold in the innermost layer, causing disruption in the layering process and may result in blow holds or exposed wire braids, which may result in further damage.

Jul 1, 2009Z-2313-2009—terminated

Misbranding--Some products may be identified with the wrong ID band content 'Neuron 6F 070' instead of 'Neuron 6F delivery'

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Penumbra Inc. Roseville, CA · US FEI 3016591327